Literature DB >> 23038629

Locus coeruleus neuron density and parkinsonism in older adults without Parkinson's disease.

Aron S Buchman1, Sukriti Nag, Joshua M Shulman, Andrew S P Lim, Veronique G J M VanderHorst, Sue E Leurgans, Julie A Schneider, David A Bennett.   

Abstract

Previous work has showed that nigral neuron density is related to the severity of parkinsonism proximate to death in older persons without a clinical diagnosis of Parkinson's disease (PD). We tested the hypothesis that neuron density in other brain stem aminergic nuclei is also related to the severity of parkinsonism. We studied brain autopsies from 125 deceased older adults without PD enrolled in the Memory and Aging Project, a clinicopathologic investigation. Parkinsonism was assessed with a modified version of the Unified Parkinson's Disease Rating Scale (UPDRS). We measured neuron density in the substantia nigra, ventral tegmental area, locus coeruleus, and dorsal raphe, along with postmortem indices of Lewy body disease, Alzheimer's disease and cerebrovascular pathologies. Mean age at death was 88.0 years, and global parkinsonism was 14.8 (SD, 9.50). In a series of regression models that controlled for demographics and neuron density in the substantia nigra, neuron density in the locus coeruleus (estimate, -0.261; SE, 0.117; P = .028) but not in the ventral tegmental area or dorsal raphe was associated with severity of global parkinsonism proximate to death. These findings were unchanged in models that controlled for postmortem interval, whole-brain weight, and other common neuropathologies including Alzheimer's disease and Lewy body pathology and cerebrovascular vascular pathologies. In older adults without a clinical diagnosis of PD, neuron density in locus coeruleus nuclei is associated with the severity of parkinsonism and may contribute to late-life motor impairments.
Copyright © 2012 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23038629      PMCID: PMC3628555          DOI: 10.1002/mds.25142

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  22 in total

1.  Nigral pathology and parkinsonian signs in elders without Parkinson disease.

Authors:  Aron S Buchman; Joshua M Shulman; Sukriti Nag; Sue E Leurgans; Steven E Arnold; Martha C Morris; Julie A Schneider; David A Bennett
Journal:  Ann Neurol       Date:  2012-02       Impact factor: 10.422

2.  Spinal projections of the A5, A6 (locus coeruleus), and A7 noradrenergic cell groups in rats.

Authors:  Eveline Bruinstroop; Georgina Cano; Veronique G J M Vanderhorst; Judney C Cavalcante; Jena Wirth; Miguel Sena-Esteves; Clifford B Saper
Journal:  J Comp Neurol       Date:  2012-06-15       Impact factor: 3.215

Review 3.  Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria.

Authors:  Dennis W Dickson; Heiko Braak; John E Duda; Charles Duyckaerts; Thomas Gasser; Glenda M Halliday; John Hardy; James B Leverenz; Kelly Del Tredici; Zbigniew K Wszolek; Irene Litvan
Journal:  Lancet Neurol       Date:  2009-12       Impact factor: 44.182

4.  Association between mild parkinsonian signs and mortality in an elderly male cohort in China.

Authors:  Guoqing Zhou; Lihui Duan; Fang Sun; Bing Yan; Suhong Ren
Journal:  J Clin Neurosci       Date:  2010-01-06       Impact factor: 1.961

5.  Mild parkinsonian signs are associated with increased risk of dementia in a prospective, population-based study of elders.

Authors:  Elan D Louis; Ming X Tang; Nicole Schupf
Journal:  Mov Disord       Date:  2010-01-30       Impact factor: 10.338

6.  Incidental Lewy body disease and preclinical Parkinson disease.

Authors:  Anthony DelleDonne; Kevin J Klos; Hiroshige Fujishiro; Zeshan Ahmed; Joseph E Parisi; Keith A Josephs; Roberta Frigerio; Melinda Burnett; Zbigniew K Wszolek; Ryan J Uitti; J Eric Ahlskog; Dennis W Dickson
Journal:  Arch Neurol       Date:  2008-08

Review 7.  Mild Parkinsonian signs: An overview of an emerging concept.

Authors:  Elan D Louis; David A Bennett
Journal:  Mov Disord       Date:  2007-09-15       Impact factor: 10.338

8.  Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease.

Authors:  Dennis W Dickson; Hiroshige Fujishiro; Anthony DelleDonne; Joshua Menke; Zeshan Ahmed; Kevin J Klos; Keith A Josephs; Roberta Frigerio; Melinda Burnett; Joseph E Parisi; J Eric Ahlskog
Journal:  Acta Neuropathol       Date:  2008-02-09       Impact factor: 17.088

9.  Combinations of motor measures more strongly predict adverse health outcomes in old age: the rush memory and aging project, a community-based cohort study.

Authors:  Aron S Buchman; Sue E Leurgans; Patricia A Boyle; Julie A Schneider; Steven E Arnold; David A Bennett
Journal:  BMC Med       Date:  2011-04-20       Impact factor: 8.775

10.  A role for locus coeruleus in Parkinson tremor.

Authors:  Ioannis U Isaias; Alberto Marzegan; Gianni Pezzoli; Giorgio Marotta; Margherita Canesi; Gabriele E M Biella; Jens Volkmann; Paolo Cavallari
Journal:  Front Hum Neurosci       Date:  2012-01-03       Impact factor: 3.169

View more
  25 in total

1.  Neural reserve, neuronal density in the locus ceruleus, and cognitive decline.

Authors:  Robert S Wilson; Sukriti Nag; Patricia A Boyle; Loren P Hizel; Lei Yu; Aron S Buchman; Julie A Schneider; David A Bennett
Journal:  Neurology       Date:  2013-03-13       Impact factor: 9.910

Review 2.  The neurobiological basis of cognitive impairment in Parkinson's disease.

Authors:  Glenda M Halliday; James B Leverenz; Jay S Schneider; Charles H Adler
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

3.  Postganglionic sympathetic neurons, but not locus coeruleus optostimulation, activates neuromuscular transmission in the adult mouse in vivo.

Authors:  Zhong-Min Wang; Maria L Messi; Valentina Grinevich; Evgeny Budygin; Osvaldo Delbono
Journal:  Mol Cell Neurosci       Date:  2020-10-08       Impact factor: 4.314

4.  Loss of Brain Norepinephrine Elicits Neuroinflammation-Mediated Oxidative Injury and Selective Caudo-Rostral Neurodegeneration.

Authors:  Sheng Song; Lulu Jiang; Esteban A Oyarzabal; Belinda Wilson; Zibo Li; Yen-Yu Ian Shih; Qingshan Wang; Jau-Shyong Hong
Journal:  Mol Neurobiol       Date:  2018-07-27       Impact factor: 5.590

5.  Cognitive frailty.

Authors:  A S Buchman; D A Bennett
Journal:  J Nutr Health Aging       Date:  2013-09       Impact factor: 4.075

6.  Spinal Arteriolosclerosis Is Common in Older Adults and Associated With Parkinsonism.

Authors:  Aron S Buchman; Sue E Leurgans; Sukriti Nag; Veronique G J M VanderHorst; Alifiya Kapasi; Julie A Schneider; David A Bennett
Journal:  Stroke       Date:  2017-09-20       Impact factor: 7.914

7.  Histologic validation of locus coeruleus MRI contrast in post-mortem tissue.

Authors:  Noam I Keren; Saeid Taheri; Elena M Vazey; Paul S Morgan; Ann-Charlotte E Granholm; Gary S Aston-Jones; Mark A Eckert
Journal:  Neuroimage       Date:  2015-03-17       Impact factor: 6.556

8.  Transcription Factors Phox2a/2b Upregulate Expression of Noradrenergic and Dopaminergic Phenotypes in Aged Rat Brains.

Authors:  Yan Fan; Fei Zeng; Russell W Brown; Jennifer B Price; Thomas C Jones; Meng-Yang Zhu
Journal:  Neurotox Res       Date:  2020-07-02       Impact factor: 3.911

9.  Parkinsonism in Older Adults and Its Association With Adverse Health Outcomes and Neuropathology.

Authors:  Aron S Buchman; R S Wilson; Joshua M Shulman; Sue E Leurgans; Julie A Schneider; David A Bennett
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-09-10       Impact factor: 6.053

Review 10.  Religious Orders Study and Rush Memory and Aging Project.

Authors:  David A Bennett; Aron S Buchman; Patricia A Boyle; Lisa L Barnes; Robert S Wilson; Julie A Schneider
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.